The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Update in global trends and aetiology of hepatocellular carcinoma
Open accessAbstract
Hepatocellular carcinoma (HCC) is the most common primary cancer of the liver responsible for an increasing number of cancer-related deaths, especially in developing economies of Asia and Africa. A plethora of risk factors have been described in the literature. Some of the important ones include chronic viral hepatitis, liver cirrhosis, environmental toxins such as aflatoxin, non-alcoholic fatty liver disease, lifestyle factors like alcohol consumption, smoking, and dietary factors, metabolic diseases like diabetes mellitus and obesity, and genetic and hereditary disorders. The development of HCC is complex involving sustained inflammatory damage leading to hepatocyte necrosis, regeneration, and fibrotic deposition. It also poses multiple challenges in diagnosis and treatment despite advances in diagnostic, surgical, and other therapeutic advancements. This is a narrative review of findings of multiple studies that were retrieved from electronic databases like PubMed, MEDLINE, Embase, Google Scholar, Scopus, and Cochrane. We summarise the current knowledge regarding the epidemiology and various risk factors for the development of HCC with a brief note on various prevention strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Vos, T., Allen, C., Arora, M., Barber, R. M., Bhutta, Z. A., Brown, A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31678-6 · Cited by 7,253
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
El-Serag, H. B. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1001683 · Cited by 3,529
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
El-Serag, H. B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.061 · Cited by 3,380
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
Chen, C.-J. (2006) · JAMA · doi:10.1001/jama.295.1.65 · Cited by 3,140
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS
Beasley, R. P., Lin, C.-C., Hwang, L.-Y., & Chien, C.-S. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90585-7 · Cited by 2,865
Schweitzer, A., Horn, J., Mikolajczyk, R. T., Krause, G., & Ott, J. J. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61412-x · Cited by 2,742
D'Amico, G., Garcia-Tsao, G., & Pagliaro, L. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.10.013 · Cited by 2,687
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
Fattovich, G., Stroffolini, T., Zagni, I., & Donato, F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.014 · Cited by 2,591
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219
Altekruse, S. F., McGlynn, K. A., & Reichman, M. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.7753 · Cited by 1,694
Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying Disease
Caldwell, S. H., Oelsner, D. H., Iezzoni, J. C., Hespenheide, E. E., Battle, E. H., & Driscoll, C. J. (1999) · Hepatology · doi:10.1002/hep.510290347 · Cited by 1,143
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
(2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.12.021 · Cited by 1,096
Reig, M., Mariño, Z., Perelló, C., Iñarrairaegui, M., Ribeiro, A., Lens, S., Díaz, A., Vilana, R., Darnell, A., Varela, M., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.008 · Cited by 1,018
Hereditary Hemochromatosis — A New Look at an Old Disease
Pietrangelo, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031573 · Cited by 992
Michelotti, G. A., Machado, M. V., & Diehl, A. M. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.183 · Cited by 974
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
Kanwal, F., Kramer, J., Asch, S. M., Chayanupatkul, M., Cao, Y., & El-Serag, H. B. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.06.012 · Cited by 931
The Epidemiology of Cirrhosis in the United States: A Population-based Study
Scaglione, S., Kliethermes, S., Cao, G., Shoham, D., Durazo, R., Luke, A., & Volk, M. L. (2015) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000208 · Cited by 683
Donato, F. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.4.323 · Cited by 677
Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team
Dyson, J., Jaques, B., Chattopadyhay, D., Lochan, R., Graham, J., Das, D., Aslam, T., Patanwala, I., Gaggar, S., Cole, M., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.08.011 · Cited by 603 · cited 1×
“In industrialised countries, fatty liver disease, apart from viral hepatitis, is closely related to nutritional factors [67].”
BackgroundLaBrecque, D. R., Abbas, Z., Anania, F., Ferenci, P., Khan, A. G., Goh, K.-L., Hamid, S. S., Isakov, V., Lizarzabal, M., Peñaranda, M. M., et al. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000116 · Cited by 519
Obesity, inflammation, and liver cancer
Sun, B., & Karin, M. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.09.020 · Cited by 496
Timms, P. M. (2002) · QJM · doi:10.1093/qjmed/95.12.787 · Cited by 462
Singh, S., Singh, P. P., Singh, A. G., Murad, M. H., & Sanchez, W. (2013) · Gastroenterology · doi:10.1053/j.gastro.2012.10.005 · Cited by 452
Rake, J. P., Visser, G., Labrune, P., Leonard, J. V., Ullrich, K., & Smit, G. P. A. (2002) · European Journal of Pediatrics · doi:10.1007/bf02679990 · Cited by 424
The global impact of vaccination against hepatitis B: A historical overview
Zanetti, A. R., Van Damme, P., & Shouval, D. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.09.056 · Cited by 420
Risk Factors for the Rising Rates of Primary Liver Cancer in the United States
El-Serag, H. B., & Mason, A. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.21.3227 · Cited by 418
Kowdley, K. V., Wang, C. C., Welch, S., Roberts, H., & Brosgart, C. L. (2012) · Hepatology · doi:10.1002/hep.24804 · Cited by 400
Population attributable fractions of risk factors for hepatocellular carcinoma in the United States
Makarova‐Rusher, O. V., Altekruse, S. F., McNeel, T. S., Ulahannan, S., Duffy, A. G., Graubard, B. I., Greten, T. F., & McGlynn, K. A. (2016) · Cancer · doi:10.1002/cncr.29971 · Cited by 332
Population-Attributable Fractions of Risk Factors for Hepatocellular Carcinoma in the United States
Welzel, T. M., Graubard, B. I., Quraishi, S., Zeuzem, S., Davila, J. A., El-Serag, H. B., & McGlynn, K. A. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.160 · Cited by 328
Non-alcoholic fatty liver disease
Sattar, N., Forrest, E., & Preiss, D. (2014) · BMJ · doi:10.1136/bmj.g4596 · Cited by 325
Lai, S.-W., Chen, P.-C., Liao, K.-F., Muo, C.-H., Lin, C.-C., & Sung, F.-C. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.384 · Cited by 313
Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta‐analysis
Wang, P., Kang, D., Cao, W., Wang, Y., & Liu, Z. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1291 · Cited by 310
Papatheodoridis, G. V., Idilman, R., Dalekos, G. N., Buti, M., Chi, H., van Boemmel, F., Calleja, J. L., Sypsa, V., Goulis, J., Manolakopoulos, S., et al. (2017) · Hepatology · doi:10.1002/hep.29320 · Cited by 301
The occurrence of hepatoma in the chronic form of hereditary tyrosinemia
Weinberg, A. G., Mize, C. E., & Worthen, H. G. (1976) · The Journal of Pediatrics · doi:10.1016/s0022-3476(76)80259-4 · Cited by 283
Global control of hepatitis C: where challenge meets opportunity
Thomas, D. L. (2013) · Nature Medicine · doi:10.1038/nm.3184 · Cited by 280
Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives
Elmberg, M., Hultcrantz, R., Ekbom, A., Brandt, L., Olsson, S., Olsson, R., Lindgren, S., Lööf, L., Stål, P., Wallerstedt, S., et al. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.035 · Cited by 273 · cited 1×
“008), especially in males with AAT deficiency, compared to the general population [89].”
BackgroundComparison of hepatocellular carcinoma in Eastern versus Western populations
Choo, S. P., Tan, W. L., Goh, B. K. P., Tai, W. M., & Zhu, A. X. (2016) · Cancer · doi:10.1002/cncr.30237 · Cited by 264
Australia Antigen and the Biology of Hepatitis B
Blumberg, B. S. (1977) · Science · doi:10.1126/science.325649 · Cited by 257
Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer
Lee, Y.-C. A., Cohet, C., Yang, Y.-C., Stayner, L., Hashibe, M., & Straif, K. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyp280 · Cited by 254
Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma
Hoshida, Y., Fuchs, B. C., Bardeesy, N., Baumert, T. F., & Chung, R. T. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.010 · Cited by 230
Cancer Burden From Arsenic in Drinking Water in Bangladesh
Chen, Y., & Ahsan, H. (2004) · American Journal of Public Health · doi:10.2105/ajph.94.5.741 · Cited by 229
Curing Chronic Hepatitis C — The Arc of a Medical Triumph
Chung, R. T., & Baumert, T. F. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1400986 · Cited by 227
Prentice, R. L., Thomson, C. A., Caan, B., Hubbell, F. A., Anderson, G. L., Beresford, S. A. A., Pettinger, M., Lane, D. S., Lessin, L., Yasmeen, S., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm159 · Cited by 213
Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer
Aleksandrova, K., Boeing, H., Nöthlings, U., Jenab, M., Fedirko, V., Kaaks, R., Lukanova, A., Trichopoulou, A., Trichopoulos, D., Boffetta, P., et al. (2014) · Hepatology · doi:10.1002/hep.27016 · Cited by 211
Liver Disease in Alpha 1-Antitrypsin Deficiency: A Review
Fairbanks, K. D., & Tavill, A. S. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01955.x · Cited by 209
Roberts, H., Kruszon‐Moran, D., Ly, K. N., Hughes, E., Iqbal, K., Jiles, R. B., & Holmberg, S. D. (2016) · Hepatology · doi:10.1002/hep.28109 · Cited by 205
Congenital heart disease and the liver
Asrani, S. K., Asrani, N. S., Freese, D. K., Phillips, S. D., Warnes, C. A., Heimbach, J., & Kamath, P. S. (2012) · Hepatology · doi:10.1002/hep.25692 · Cited by 199
Scott, C. R. (2006) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.30092 · Cited by 186
Wang, J. S., Huang, T., Su, J., et al. (2001) · PubMed · Cited by 170
Hepatitis Viruses, Alcohol, and Tobacco in the Etiology of Hepatocellular Carcinoma in Italy
Franceschi, S., Montella, M., Polesel, J., La Vecchia, C., Crispo, A., Dal Maso, L., Casarin, P., Izzo, F., Tommasi, L. G., Chemin, I., et al. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0702 · Cited by 162
Liver Fibrogenesis: A New Role for the Renin–Angiotensin System
Bataller, R. A., Sancho‐Bru, P., Ginès, P., & Brenner, D. A. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.1346 · Cited by 155
Schlesinger, S., Aleksandrova, K., Pischon, T., Jenab, M., Fedirko, V., Trépo, E., Overvad, K., Roswall, N., Tjønneland, A. M., Boutron‐Ruault, M., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt204 · Cited by 149
Andant, C., Puy, H., Bogard, C., Faivre, J., Soulé, J.-C., NORDMANN, Y., & Deybach, J. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80097-5 · Cited by 148
Gallstones, Cholecystectomy, and Risk of Digestive System Cancers
Nogueira, L., Freedman, N. D., Engels, E. A., Warren, J. L., Castro, F. A., & Koshiol, J. E. (2014) · American Journal of Epidemiology · doi:10.1093/aje/kwt322 · Cited by 143
Yang, Y., Zhang, D., Feng, N., Chen, G., Liu, J., Chen, G., & Zhu, Y. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.005 · Cited by 140
Environmental and occupational exposure to chemicals and telomere length in human studies
Zhang, X., Lin, S., Funk, W. E., & Hou, L. (2013) · Occupational and Environmental Medicine · doi:10.1136/oemed-2012-101350 · Cited by 137
Cancer in experimental animals exposed to arsenic and arsenic compounds
Tokar, E. J., Benbrahim‐Tallaa, L., Ward, J. M., Lunn, R. M., Sams, R. L., & Waalkes, M. P. (2010) · Critical Reviews in Toxicology · doi:10.3109/10408444.2010.506641 · Cited by 133
Jin-no, K., Tanimizu, M., Hyodo, I., Nishikawa, Y., Hosokawa, Y., Doi, T., Endo, H., Yamashita, T., & Okada, Y. (1998) · Journal of Gastroenterology · doi:10.1007/s005350050099 · Cited by 126
Increased Risk for Malignant Neoplasms Among Patients With Cirrhosis
Kalaitzakis, E., Gunnarsdóttir, S. A., Josefsson, A., & Bjornsson, E. S. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.10.014 · Cited by 121
Chen, S., Wang, L., Lunn, R. M., Tsai, W., Lee, P., Lee, C., Ahsan, H., Zhang, Y., Chen, C., & Santella, R. M. (2002) · International Journal of Cancer · doi:10.1002/ijc.10291 · Cited by 120
Feo, F., Miglio, M. R. D., Simile, M. M., Muroni, M. R., Calvisi, D. F., Frau, M., & Pascale, R. M. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.08.007 · Cited by 112
Yokohama, S., Tokusashi, Y., Nakamura, K., Tamaki, Y., Okamoto, S., Okada, M., Aso, K., Hasegawa, T., Aoshima, M., Miyokawa, N., et al. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i2.322 · Cited by 111
Role of Alcohol in Liver Carcinogenesis
McKillop, I. H., & Schrum, L. W. (2009) · Seminars in Liver Disease · doi:10.1055/s-0029-1214377 · Cited by 111
Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
Livingston, S. (2003) · PsycEXTRA Dataset · doi:10.1037/e507242006-002 · Cited by 111
Fedirko, V., Duarte‐Salles, T., Bamia, C., Trichopoulou, A., Aleksandrova, K., Trichopoulos, D., Trépo, E., Tjønneland, A. M., Olsen, A., Overvad, K., et al. (2014) · Hepatology · doi:10.1002/hep.27079 · Cited by 108
Elzouki, A.-N., & Eriksson, S. (1996) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199610000-00010 · Cited by 102
Hepatitis B vaccination and prevention of hepatocellular carcinoma
Kao, J. (2015) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2015.09.011 · Cited by 99
Fedirko, V., Trichopolou, A., Bamia, C., Duarte‐Salles, T., Trépo, E., Aleksandrova, K., Nöthlings, U., Lukanova, A., Λάγιου, Π., Boffetta, P., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt168 · Cited by 97
Porphyria Cutanea Tarda and Hepatocellular Carcinoma
Salata, H., Cortés, J. M. S., de Salamanca, R. E., Oliva, H., Castro, A., Kusak, E., Carréño, V., & Guio, C. H. (1985) · Journal of Hepatology · doi:10.1016/s0168-8278(85)80746-7 · Cited by 96
Koh, W.-P., Wang, R., Jin, A., Yu, M. C., & Yuan, J.-M. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.25 · Cited by 96
Tumor suppressor and hepatocellular carcinoma
Martin, J. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.1720 · Cited by 89
Liver Fibrosis: Causes and Methods of Assessment, A Review
Erfani, A. (2015) · Romanian Journal of Internal Medicine · doi:10.1515/rjim-2015-0039 · Cited by 88
Groß‐Steinmeyer, K., Stapleton, P. L., Tracy, J. H., Bammler, T. K., Strom, S. C., & Eaton, D. L. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq135 · Cited by 87
Betel quid chewing as a risk factor for hepatocellular carcinoma: a case–control study
Tsai, J., Chuang, L., Jeng, J., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.1999.1597 · Cited by 83
Fracanzani, A. L., Taioli, E., Sampietro, M., Fatta, E., Bertelli, C., Fiorelli, G., & Fargion, S. R. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00160-x · Cited by 81
Targeting gut flora to prevent progression of hepatocellular carcinoma
Darnaud, M., Faivre, J., & Moniaux, N. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.08.019 · Cited by 80
Zhang, X., Lin, S., Funk, W. E., & Hou, L. (2013) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2012-101350rep · Cited by 77
Bartsch, H., Rojas, M., Nair, U., Nair, J., & Alexandrov, K. (1999) · Cancer Detection and Prevention · doi:10.1046/j.1525-1500.1999.99055.x · Cited by 75
Madden, C. R., Finegold, M. J., & Slagle, B. L. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11770-11774.2002 · Cited by 73
Li, C., Deng, M., Hu, J., Li, X., Chen, L., Ju, Y., Hao, J., & Meng, S. (2016) · Oncotarget · doi:10.18632/oncotarget.7740 · Cited by 70
Kuo, T.-C., & Chao, C. C. ‐. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.003 · Cited by 68
Stasi, C., Silvestri, C., Voller, F., & Cipriani, F. (2015) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2015.05.004 · Cited by 66
Dichlorodiphenyltrichloroethane and risk of hepatocellular carcinoma
Persson, E. C., Graubard, B. I., Evans, A. A., London, W. T., Weber, J., LeBlanc, A., Chen, G., Lin, W., & McGlynn, K. A. (2012) · International Journal of Cancer · doi:10.1002/ijc.27459 · Cited by 61
Wu, G. H., Boucher, B. J., Chiu, Y., Liao, C., & Chen, T. H.-H. (2008) · Public Health Nutrition · doi:10.1017/s1368980008002073 · Cited by 59
Carcinogenicity study of trichloroethylene, with and without epoxide stabilizer, in mice
Henschler, D., Els�sser, H. M., Romen, W., & Eder, E. (1984) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01032599 · Cited by 57
Type 2 Diabetes and Hepatocellular Carcinoma: Risk Factors and Pathogenesis
Wainwright, P., Scorletti, E., & Byrne, C. D. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0851-x · Cited by 52
Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play
Charrez, B., Qiao, L., & Hebbard, L. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i8.2494 · Cited by 50
Cheng, J. C., Hsu, C.-Y., Hashem, S. A., & Dawson, L. A. (2012) · Springer eBooks · doi:10.1007/978-3-642-28860-9_16 · Cited by 44
Choi, J. E., Park, S. H., Kim, K. M., Lee, W. K., Kam, S., Ick, S., Kim, C. H., Kang, Y. M., Kim, Y., Han, S. B., et al. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-199 · Cited by 43
Risk of Primary Liver Cancer Associated with Gallstones and Cholecystectomy: A Meta-Analysis
Liu, Y., He, Y. L., Li, T., Xie, L., Wang, J., Qin, X. Y., & Li, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109733 · Cited by 39
A meta-analysis of occupational trichloroethylene exposure and liver cancer
Alexander, D. D., Kelsh, M. A., Mink, P. J., Mandel, J. H., Basu, R., & Weingart, M. (2007) · International Archives of Occupational and Environmental Health · doi:10.1007/s00420-007-0201-4 · Cited by 35
Arem, H. E., Loftfield, E., Saint‐Maurice, P. F., Freedman, N. D., & Matthews, C. E. (2018) · Cancer Medicine · doi:10.1002/cam4.1343 · Cited by 28
Ulbrichová, D., Hrdinka, M., Saudek, V., & Pavel Martasek, E. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.06946.x · Cited by 14
Non-Alcoholic Steatohepatitis, Liver Cirrhosis and Hepatocellular Carcinoma: The Molecular Pathways
Mezale, D., Štrumfa, I., Vanags, A., Mežals, M., Fridrihsone, I., Štrumfs, B., & Balodis, D. (2017) · InTech eBooks · doi:10.5772/intechopen.68771 · Cited by 14
Pinyol, R., Montal, R., Takayama, T., Chau, G., Mazzaferro, V., Roayaie, S., Lee, H. C., Poon, R. T. P., Kokudo, N., Zhang, Z., et al. (2017) · Journal of Hepatology · doi:10.1016/s0168-8278(17)30287-8 · Cited by 6
Nonalcoholic Fatty Liver Disease
Fitzpatrick, E. (2015) · Springer eBooks · doi:10.1007/978-3-319-17169-2_66 · Cited by 3
Cited by
Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors
Rawla, P., Sunkara, T., & Barsouk, A. (2019) · Gastroenterology Review · doi:10.5114/pg.2018.81072 · Cited by 2,323
Self-citationDe Cicco, P., Ercolano, G., & Ianaro, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01680 · Cited by 332
In Vitro Three‐Dimensional Liver Models for Nanomaterial DNA Damage Assessment
Llewellyn, S. V., Niemeijer, M., Nymark, P., Moné, M. J., van de Water, B., Conway, G. E., Jenkins, G. J. S., & Doak, S. H. (2021) · Small · doi:10.1002/smll.202006055 · Cited by 41
Metadata
- Authors
- Rawla, P., Sunkara, T., Muralidharan, P., & Raj, J. P.
- Venue
- Współczesna Onkologia
- Publisher
- Termedia Sp. z.o.o.
- Published
- 2018
- Volume
- 22
- Issue
- 3
- Pages
- 141-150
- ISSN
- 1428-2526 (ISSN-L)
- OpenAlex
- W2898568606
- Cited by
- 332
- References
- 101
- FWCI
- 22.13
- Type
- journal article
- Language
- pl
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.